Abstract

Comparing the Clinical Efficacy of TKI Alone With TKI Plus Concomitant WBRT for EGFR Mutation–Positive Lung Adenocarcinoma Patients With Brain Metastases: A Retrospective Study

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call